Biohaven .(BHVN) - 2025 Q1 - Quarterly Results

Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments NEW HAVEN, Conn., May 12, 2025 /PRNewswire/ – Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life- changing therapies to treat a broad range of rare and common diseases, today reported financial results for the first quarter ended March 31, 2025, and provided a review of recent accomplishments and antici ...